AR026068A1 - Peptidos modificados y peptidomimeticos para el uso en inmunoterapia. - Google Patents
Peptidos modificados y peptidomimeticos para el uso en inmunoterapia.Info
- Publication number
- AR026068A1 AR026068A1 ARP000105458A ARP000105458A AR026068A1 AR 026068 A1 AR026068 A1 AR 026068A1 AR P000105458 A ARP000105458 A AR P000105458A AR P000105458 A ARP000105458 A AR P000105458A AR 026068 A1 AR026068 A1 AR 026068A1
- Authority
- AR
- Argentina
- Prior art keywords
- amino acids
- formula
- substitution
- ser
- thr
- Prior art date
Links
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 238000009169 immunotherapy Methods 0.000 title 1
- 239000000816 peptidomimetic Substances 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 4
- 238000006467 substitution reaction Methods 0.000 abstract 4
- 238000012986 modification Methods 0.000 abstract 2
- 230000004048 modification Effects 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 230000006698 induction Effects 0.000 abstract 1
- 108091005601 modified peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rehabilitation Therapy (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99203427 | 1999-10-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR026068A1 true AR026068A1 (es) | 2002-12-26 |
Family
ID=8240756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000105458A AR026068A1 (es) | 1999-10-18 | 2000-10-18 | Peptidos modificados y peptidomimeticos para el uso en inmunoterapia. |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1226167A1 (cs) |
| JP (1) | JP2003512388A (cs) |
| KR (1) | KR20020047245A (cs) |
| CN (1) | CN1379786A (cs) |
| AR (1) | AR026068A1 (cs) |
| AU (1) | AU780238B2 (cs) |
| BR (1) | BR0014803A (cs) |
| CA (1) | CA2386398A1 (cs) |
| CO (1) | CO5271650A1 (cs) |
| CZ (1) | CZ20021356A3 (cs) |
| HK (1) | HK1046693A1 (cs) |
| HU (1) | HUP0203504A3 (cs) |
| IL (1) | IL148778A0 (cs) |
| MX (1) | MXPA02003520A (cs) |
| NO (1) | NO20021763L (cs) |
| NZ (1) | NZ518256A (cs) |
| PE (1) | PE20010692A1 (cs) |
| PL (1) | PL354590A1 (cs) |
| RU (1) | RU2002113107A (cs) |
| SK (1) | SK6842002A3 (cs) |
| TR (1) | TR200201036T2 (cs) |
| WO (1) | WO2001029081A1 (cs) |
| ZA (1) | ZA200202577B (cs) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002951212A0 (en) * | 2002-09-04 | 2002-09-19 | Monash University | A method of modulating cellular activity and molecules for use therein |
| US20100240137A1 (en) * | 2006-04-06 | 2010-09-23 | Purdue Research Foundation | Derivatization-enhanced analysis of amino acids and peptides |
| WO2008078190A2 (en) * | 2006-12-21 | 2008-07-03 | Universite De Geneve | Compounds for fluorescence imaging |
| NZ586909A (en) | 2008-01-23 | 2012-05-25 | Herlev Hospital | Ykl-40 as a general marker for non-specific disease |
| US8580520B2 (en) | 2008-09-15 | 2013-11-12 | Herlev Hospital | YKL-40 as a marker for gastrointestinal cancers |
| JP6798998B2 (ja) * | 2014-11-07 | 2020-12-09 | キネタ・クロニック・ペイン・リミテッド・ライアビリティ・カンパニーＫｉｎｅｔａ Ｃｈｒｏｎｉｃ Ｐａｉｎ， ＬＬＣ | コノトキシンペプチドの修飾および使用 |
| EP3466963A1 (en) * | 2017-10-05 | 2019-04-10 | Suigeneris Farmacosmetics, S.L. | Anticancer peptides and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL115744A (en) * | 1994-10-27 | 2000-07-16 | Akzo Nobel Nv | Peptides comprising a subsequence of human cartilage glycoprotein - 39 |
| TW575583B (en) * | 1996-04-24 | 2004-02-11 | Akzo Nobel Nv | Novel peptides suitable for use in antigen specific immunosuppressive therapy |
| NZ332347A (en) * | 1996-06-07 | 2000-05-26 | Zeneca Ltd | Peptide derivatives containing a hydrophobic group, L-amino acid residues and modified L-amino acid residues |
| IL122233A (en) * | 1996-12-06 | 2001-04-30 | Akzo Nobel Nv | Method of generating monoclonal antibodies to cell wall and pharmaceutical preparations and diagnostic agents containing them |
-
2000
- 2000-10-12 MX MXPA02003520A patent/MXPA02003520A/es unknown
- 2000-10-12 AU AU11396/01A patent/AU780238B2/en not_active Ceased
- 2000-10-12 HU HU0203504A patent/HUP0203504A3/hu unknown
- 2000-10-12 CZ CZ20021356A patent/CZ20021356A3/cs unknown
- 2000-10-12 HK HK02108208.9A patent/HK1046693A1/zh unknown
- 2000-10-12 SK SK684-2002A patent/SK6842002A3/sk not_active Application Discontinuation
- 2000-10-12 PL PL00354590A patent/PL354590A1/xx not_active Application Discontinuation
- 2000-10-12 IL IL14877800A patent/IL148778A0/xx unknown
- 2000-10-12 TR TR2002/01036T patent/TR200201036T2/xx unknown
- 2000-10-12 WO PCT/EP2000/010230 patent/WO2001029081A1/en not_active Ceased
- 2000-10-12 JP JP2001531879A patent/JP2003512388A/ja not_active Withdrawn
- 2000-10-12 KR KR1020027004940A patent/KR20020047245A/ko not_active Withdrawn
- 2000-10-12 CA CA002386398A patent/CA2386398A1/en not_active Abandoned
- 2000-10-12 RU RU2002113107/15A patent/RU2002113107A/ru not_active Application Discontinuation
- 2000-10-12 NZ NZ518256A patent/NZ518256A/en unknown
- 2000-10-12 CN CN00814418A patent/CN1379786A/zh active Pending
- 2000-10-12 EP EP00972790A patent/EP1226167A1/en not_active Withdrawn
- 2000-10-12 BR BR0014803-2A patent/BR0014803A/pt not_active IP Right Cessation
- 2000-10-17 PE PE2000001107A patent/PE20010692A1/es not_active Application Discontinuation
- 2000-10-18 AR ARP000105458A patent/AR026068A1/es unknown
- 2000-10-18 CO CO00079334A patent/CO5271650A1/es not_active Application Discontinuation
-
2002
- 2002-04-02 ZA ZA200202577A patent/ZA200202577B/en unknown
- 2002-04-15 NO NO20021763A patent/NO20021763L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20021763D0 (no) | 2002-04-15 |
| HK1046693A1 (zh) | 2003-01-24 |
| CO5271650A1 (es) | 2003-04-30 |
| AU780238B2 (en) | 2005-03-10 |
| WO2001029081A1 (en) | 2001-04-26 |
| CN1379786A (zh) | 2002-11-13 |
| PE20010692A1 (es) | 2001-07-06 |
| CZ20021356A3 (cs) | 2002-07-17 |
| ZA200202577B (en) | 2003-09-23 |
| HUP0203504A2 (hu) | 2003-04-28 |
| RU2002113107A (ru) | 2004-01-10 |
| MXPA02003520A (es) | 2002-08-20 |
| CA2386398A1 (en) | 2001-04-26 |
| EP1226167A1 (en) | 2002-07-31 |
| NZ518256A (en) | 2004-01-30 |
| KR20020047245A (ko) | 2002-06-21 |
| HUP0203504A3 (en) | 2005-03-29 |
| TR200201036T2 (tr) | 2002-08-21 |
| AU1139601A (en) | 2001-04-30 |
| NO20021763L (no) | 2002-04-15 |
| PL354590A1 (en) | 2004-01-26 |
| SK6842002A3 (en) | 2002-09-10 |
| IL148778A0 (en) | 2002-09-12 |
| JP2003512388A (ja) | 2003-04-02 |
| BR0014803A (pt) | 2002-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5700784A2 (es) | Polipeptidos de virus de papiloma humano y composiciones in- munogenas | |
| ES2564463T3 (es) | Péptidos antigénicos de Neisseriales | |
| ES2178000T3 (es) | Composiciones y metodos para tratar infecciones usando analogos de indolicidina. | |
| ATE280826T1 (de) | Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen | |
| DE60045524D1 (de) | Ein Huhn GnRH-II Analog zur Verwendung in der Reduktion des Tumorzellwachstums | |
| DE60030450D1 (de) | Von MUC-1 abgeleitete Peptide | |
| TR199802534T2 (xx) | Leptin (OB Protein) fragmanlar� | |
| ATE489462T1 (de) | Antimikrobielles polypeptid und nutzung davon | |
| ES2174770T1 (es) | Peptidos diseñados para el diagnostico y el tratamiento de artritis reumatoide. | |
| YU53803A (sh) | Peptidi i/ili proteini kao i njihova primena za pripremanje terapeutskih i/ili preventivnih lekova | |
| DK0491628T3 (da) | Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner | |
| DE602004028266D1 (de) | Angiogene peptide und ihre verwendungen | |
| CO5271650A1 (es) | Peptidos modificados y peptidomimeticos para el uso en inmunoterapia | |
| AR004497A1 (es) | Un análogo hexapéptido cíclico de somatostatina, procedimiento para prepararlos y las composiciones farmacéuticas que los contienen y el uso de dicho hexapéptido para la preparación de una composición farmacéutica. | |
| ATE355302T1 (de) | N-substituierte d-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation | |
| SG162791A1 (en) | Mucin hypersecretion inhibitors based on the structure of mans and methods of use | |
| PT1691827E (pt) | Utilização de péptidos derivados da cadeia b beta de fibrinogénio humano para o tratamento do choque | |
| DE69938130D1 (de) | Neue peptide | |
| TW200505943A (en) | Polypeptide | |
| AR044852A1 (es) | Una composicion farmaceutica para la administracion parenteral que comprende un analogo de somatostatina | |
| DK1504036T3 (da) | Toxinrelaterede fragmenter af antistoffer med antimikrobiel og antiviral aktivitet | |
| ECSP003720A (es) | Peptidos modificados y peptidomimeticos para el uso en inmunoterapia | |
| DE602004019141D1 (de) | Isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonin (ivtntt) enthaltende biologisch wirksame peptide | |
| SE9700301D0 (sv) | New compound | |
| ID27162A (id) | Peptida antigen tumor yang dibatasi hla-a2 yang berasal dari sart-1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |